DE602004025265D1 - Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon - Google Patents
Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davonInfo
- Publication number
- DE602004025265D1 DE602004025265D1 DE602004025265T DE602004025265T DE602004025265D1 DE 602004025265 D1 DE602004025265 D1 DE 602004025265D1 DE 602004025265 T DE602004025265 T DE 602004025265T DE 602004025265 T DE602004025265 T DE 602004025265T DE 602004025265 D1 DE602004025265 D1 DE 602004025265D1
- Authority
- DE
- Germany
- Prior art keywords
- sequence
- phosphat
- new
- pharmaceutical compositions
- binding protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0312729A FR2861731B1 (fr) | 2003-10-30 | 2003-10-30 | Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations |
PCT/FR2004/002797 WO2005042572A1 (fr) | 2003-10-30 | 2004-10-29 | Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004025265D1 true DE602004025265D1 (de) | 2010-03-11 |
Family
ID=34429758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004025265T Active DE602004025265D1 (de) | 2003-10-30 | 2004-10-29 | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon |
Country Status (11)
Country | Link |
---|---|
US (1) | US7718773B2 (de) |
EP (1) | EP1678204B1 (de) |
JP (1) | JP4728246B2 (de) |
CN (1) | CN1898261B (de) |
AT (1) | ATE455792T1 (de) |
CA (1) | CA2543935C (de) |
DE (1) | DE602004025265D1 (de) |
ES (1) | ES2341174T3 (de) |
FR (1) | FR2861731B1 (de) |
IL (1) | IL175319A (de) |
WO (1) | WO2005042572A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
WO2007076520A2 (en) | 2005-12-29 | 2007-07-05 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
KR20140019479A (ko) | 2005-12-29 | 2014-02-14 | 베링거잉겔하임베트메디카인코퍼레이티드 | 돼지에서 임상 증상을 경감시키기 위한 pcv2 면역원성 조성물의 용도 |
US20100136060A1 (en) * | 2006-11-22 | 2010-06-03 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing porcine circovirus-associated disease outbreaks |
EP2859900A1 (de) * | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Wirksames Verfahren zur Behandlung von Infektionen mit dem porcinen Circovirus und Lawsonia intracellularis |
ES2625460T5 (es) * | 2006-12-15 | 2020-11-04 | Boehringer Ingelheim Animal Health Usa Inc | Tratamiento de cerdos seropositivos en anticuerpo anti-PCV2 con antígeno de PCV2 |
EP1941903A1 (de) * | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxe und Behandlung von PRDC |
EP1958644A1 (de) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Vorbeugung und Behandlung von subklinischer PCVD |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
CN101932336B (zh) * | 2007-12-31 | 2014-07-09 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 有外来氨基酸插入的pcv2 orf2病毒样颗粒 |
CN101980720A (zh) | 2008-01-23 | 2011-02-23 | 贝林格尔.英格海姆维特梅迪卡有限公司 | Pcv2猪肺炎支原体致免疫组合物及其制备方法 |
FR2942717B1 (fr) | 2009-03-04 | 2011-08-12 | Centre Nat Rech Scient | Nouvel agent antiviral |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
WO2014014918A2 (en) * | 2012-07-16 | 2014-01-23 | St. Luke's-Roosevelt Hospital Center | X-ding-cd4 peptide |
EA035265B1 (ru) | 2013-10-02 | 2020-05-21 | Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. | Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2334905A1 (en) * | 1998-06-12 | 1999-12-23 | Gordon J. Hoover | Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents |
US20030158115A1 (en) * | 2000-03-28 | 2003-08-21 | Toback F. Gary | Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells |
-
2003
- 2003-10-30 FR FR0312729A patent/FR2861731B1/fr not_active Expired - Fee Related
-
2004
- 2004-10-29 CA CA2543935A patent/CA2543935C/fr not_active Expired - Fee Related
- 2004-10-29 WO PCT/FR2004/002797 patent/WO2005042572A1/fr active Application Filing
- 2004-10-29 US US10/577,658 patent/US7718773B2/en not_active Expired - Fee Related
- 2004-10-29 EP EP04805350A patent/EP1678204B1/de not_active Not-in-force
- 2004-10-29 AT AT04805350T patent/ATE455792T1/de not_active IP Right Cessation
- 2004-10-29 CN CN2004800382227A patent/CN1898261B/zh not_active Expired - Fee Related
- 2004-10-29 DE DE602004025265T patent/DE602004025265D1/de active Active
- 2004-10-29 JP JP2006537368A patent/JP4728246B2/ja not_active Expired - Fee Related
- 2004-10-29 ES ES04805350T patent/ES2341174T3/es active Active
-
2006
- 2006-04-30 IL IL175319A patent/IL175319A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2005042572A1 (fr) | 2005-05-12 |
ES2341174T3 (es) | 2010-06-16 |
FR2861731A1 (fr) | 2005-05-06 |
JP2008502305A (ja) | 2008-01-31 |
CN1898261B (zh) | 2011-08-17 |
EP1678204A1 (de) | 2006-07-12 |
FR2861731B1 (fr) | 2006-02-24 |
IL175319A (en) | 2013-07-31 |
JP4728246B2 (ja) | 2011-07-20 |
CA2543935A1 (fr) | 2005-05-12 |
CA2543935C (fr) | 2014-12-02 |
ATE455792T1 (de) | 2010-02-15 |
US20070196879A1 (en) | 2007-08-23 |
US7718773B2 (en) | 2010-05-18 |
CN1898261A (zh) | 2007-01-17 |
EP1678204B1 (de) | 2010-01-20 |
IL175319A0 (en) | 2006-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175319A0 (en) | Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof | |
AU2003264419A1 (en) | Kdr peptides and vaccines containing the same | |
IN2015DN02553A (de) | ||
AU2002305450A1 (en) | Proteomimetic compounds and methods | |
DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
EP2039367A4 (de) | Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen | |
WO2006028561A3 (en) | Novel purified fabi polypeptides from fransicella tularensis | |
ATE495247T1 (de) | Chromoprotein und fluoroproteine | |
WO2007013358A3 (en) | Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent | |
ATE551353T1 (de) | Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten | |
AU2003251728A1 (en) | Placental growth factor as a target for the treatment of osteoporosis | |
WO2005086595A3 (ja) | テロメアタンパク質trf2dna結合ドメイン変異体タンパク質、テロメアdna変異体及びtrf2dna結合ドメインと二重らせんdnaとの複合体構造の利用 | |
WO2004011638A3 (en) | Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures | |
PT1401871E (pt) | Moleculas de ligacao imunologicas que inibem a fusao sincicial de celulas do tropoblasto | |
WO2004013167A3 (en) | Purified polypeptides from enterococcus faecalis | |
WO2005087809B1 (en) | Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion | |
WO2009014160A1 (ja) | 膵癌の新規腫瘍マーカー | |
WO2004081165A3 (en) | Novel purified dihydrodipicolinate synthase polypeptides and structures thereof | |
NZ603077A (en) | Biological materials and uses thereof | |
WO2004042044A3 (en) | Crystal structures of bacterial guanylate kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |